Management of neuropsychiatric symptoms in people with dementia.
Neuropsychiatric symptoms are frequent and troublesome in people with dementia and present a major treatment challenge for clinicians. Most good practice guidelines suggest non-pharmacological treatments as the first-line therapy and there is emerging evidence, including randomized controlled trials, that a variety of psychological and training interventions, including social interaction and person-centred care training, are effective. There is evidence from meta-analyses that some atypical antipsychotic drugs, specifically risperidone and aripiprazole, confer benefit in the treatment of aggression in people with Alzheimer's disease over a period of up to 12 weeks. However, these benefits have to be considered in the context of significant adverse events, including extrapyramidal symptoms, accelerated cognitive decline, stroke and death. In addition, the limited evidence available does not indicate ongoing treatment benefits over longer periods of therapy. The evidence is limited for other pharmacological treatment approaches, but the best evidence is probably for carbamazepine, memantine and citalopram. There is very limited evidence for any therapies in non-Alzheimer dementias. In conclusion, it is important in most situations to limit the use of antipsychotic medication to short-term treatment (up to 12 weeks) of severe neuropsychiatric symptoms to limit harm. Non-pharmacological therapies offer a viable and effective alternative in many situations. Adequately powered randomized controlled trials for the treatment of clinically significant agitation are urgently needed to explore alternative pharmacological therapies.
Ballard
Clive
C
Wolfson Centre for Age-Related Diseases, King's College London, London, UK. clive.ballard@kcl.ac.uk
Corbett
Anne
A
D000374:Aggression / Q000187:drug effects* / Q000523:psychology; D002491:Central Nervous System Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000529:Complementary Therapies; D003704:Dementia / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D004334:Drug Administration Schedule; D006801:Humans; D011595:Psychomotor Agitation / Q000523:psychology / Q000628:therapy*
D002491:Central Nervous System Agents
Am J Psychiatry. 2004 Jun;161(6):1113-5
15169702
BMJ. 2006 Apr 1;332(7544):756-61
16543297
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154
16625572
Neurology. 2000 Nov 14;55(9):1271-8
11087767
Lancet. 2000 Mar 25;355(9209):1048-52
10744090
Am J Psychiatry. 2008 Jul;165(7):844-54
18519523
Dement Geriatr Cogn Disord. 2003;15(2):99-105
12566599
N Engl J Med. 2006 Oct 12;355(15):1525-38
17035647
Int Psychogeriatr. 2002 Dec;14(4):389-404
12670060
Am J Psychiatry. 1998 Nov;155(11):1512-20
9812111
J Neuropsychiatry Clin Neurosci. 1996 Summer;8(3):270-5
8854297
Int J Geriatr Psychiatry. 2001 Oct;16(10):1010-3
11607948
Lancet Neurol. 2009 Apr;8(4):317-25
19282246
J Neuropsychiatry Clin Neurosci. 1997 Fall;9(4):591-3
9447502
Int J Geriatr Psychiatry. 2008 May;23(5):537-45
18058838
J Clin Psychiatry. 1979 Oct;40(10):411-9
489517
Int J Geriatr Psychiatry. 2004 Jan;19(1):9-18
14716694
Lancet Neurol. 2009 Feb;8(2):151-7
19138567
Am J Geriatr Psychiatry. 2006 Mar;14(3):280-91
16505133
J Neuropsychiatry Clin Neurosci. 1991 Fall;3(4):371-6
1821255
Nat Rev Neurosci. 2006 Jun;7(6):492-500
16715057
Cochrane Database Syst Rev. 2002 Oct 21;(4):CD003944
12519625
Int J Geriatr Psychiatry. 2007 May;22(5):405-10
17342790
J Clin Psychopharmacol. 2005 Oct;25(5):463-7
16160622
JAMA. 2003 Jan 8;289(2):210-6
12517232
Arch Gen Psychiatry. 2003 Jul;60(7):737-46
12860778
N Engl J Med. 2007 Oct 4;357(14):1382-92
17914039
Arch Gen Psychiatry. 2000 Oct;57(10):968-76
11015815
JAMA. 2003 Oct 15;290(15):2015-22
14559955
Am J Geriatr Psychiatry. 2001 Fall;9(4):400-5
11739066
JAMA. 2005 Oct 19;294(15):1934-43
16234500
PLoS Med. 2008 Apr 1;5(4):e76
18384230
N Engl J Med. 2005 Dec 1;353(22):2335-41
16319382
Lancet. 2000 Dec 16;356(9247):2031-6
11145488
Int J Geriatr Psychiatry. 2008 Feb;23(2):170-7
17607801
Am J Geriatr Psychiatry. 1997 Winter;5(1):60-9
9169246
BMJ. 2005 Feb 26;330(7489):445
15668211
BMJ. 1992 Sep 19;305(6855):673-8
1356550
J Am Geriatr Soc. 1996 Jan;44(1):7-13
8537594
BMJ. 2002 Dec 7;325(7376):1312-3
12468458
Am J Psychiatry. 1989 Jan;146(1):45-9
2643356
Neurology. 1999 Sep 22;53(5):946-55
10496251
J Am Geriatr Soc. 1990 May;38(5):553-63
1970586
Am J Psychiatry. 2000 May;157(5):708-14
10784462
J Clin Psychiatry. 2008 Mar;69(3):341-8
18294023
Clin Ther. 1984;6(4):546-59
6380725
Am J Geriatr Psychiatry. 2007 Nov;15(11):918-31
17974864
Am J Psychiatry. 1982 Sep;139(9):1170-4
7114310
BMJ. 1997 Jan 25;314(7076):266-70
9022490
JAMA. 1982 Jul 16;248(3):333-5
7087127
Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210
16505124
Psychopharmacology (Berl). 2000 Mar;148(4):361-6
10928308
J Clin Psychiatry. 2002 Jul;63(7):553-8
12143909
BMJ. 2005 Apr 16;330(7496):874
15722369
Am J Geriatr Psychiatry. 2007 Nov;15(11):942-52
17846102
Am J Psychiatry. 2002 Mar;159(3):460-5
11870012
Int Psychogeriatr. 2008 Apr;20(2):293-308
18047764
Int J Geriatr Psychiatry. 2001 Jan;16(1):39-44
11180484
Cochrane Database Syst Rev. 2001;(4):CD002852
11687166
Int J Geriatr Psychiatry. 2002 Apr;17(4):305-8
11994882
J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):908-16
17702884
BMJ. 1996 Apr 13;312(7036):947
8616308
Am J Psychiatry. 2005 Nov;162(11):1996-2021
16263837
Am J Geriatr Psychiatry. 2008 Jul;16(7):537-50
18591574
Br J Psychiatry. 1990 Jul;157:86-94
2397368
Psychiatr Clin North Am. 1991 Jun;14(2):353-73
1676507
Neurology. 2004 Jul 27;63(2):214-9
15277611
Am J Geriatr Psychiatry. 2006 Jul;14(7):561-72
16816009
Am J Psychiatry. 1998 Jan;155(1):54-61
9433339
J Gerontol B Psychol Sci Soc Sci. 1997 Jul;52(4):P159-66
9224439
Am J Psychiatry. 1990 Aug;147(8):1049-51
2375439